A recent study used integrative tissue‐omics to identify high YWHAZ expression subgroups, correlating with a high risk of disease progression, making YWHAZ a molecular biomarker associated with aggressive PCa (Lage‐Vickers et al., 2021). The gene discussed is YWHAZ; the disease is posterior cortical atrophy.